IL23R and colorectal carcinoma: (7) Moreover, targeting Treg cells or inhibiting their suppressive function is a promising treatment modality for CRC (8), but the role of IL-23R signaling in Treg cells in CRC has not been studied in a physiologically relevant cancer model (9).